Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting

January 18, 2016 updated by: Eva Serlachius, Karolinska Institutet
An open trial will be conducted at the Child and Mental Health Service (CAMHS) unit in the rural county Jämtland in Sweden to test the feasibility and efficacy of Internet-delivered Cognitive Behavior Therapy (ICBT) for children with anxiety disorders in a clinical setting. 20 children with a principal diagnosis of Generalized Anxiety Disorder (GAD), separation anxiety, specific phobia and their parents will be recruited from the CAMHS-center in Östersund. They will receive 12 weeks of therapist-supported ICBT and will be assessed by clinician ratings and child- and parent-reports at baseline, post-treatment and 3 month follow-up. The primary outcome measures the Clinical Global Impressions - Severity scale (CGI-S). Secondary outcome measures include clinician rated global functioning, and child and parent-rated anxiety and functioning.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jämtland
      • Östersund, Jämtland, Sweden, 83183
        • Child and Adolescent Mental Health Services Östersund

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 8-12 years of age
  • Fulfilling diagnostic criteria for Generalized Anxiety Disorder (GAD), Separation anxiety, Specific phobia
  • Ability to read and write Swedish
  • Daily access to the internet
  • A parent that is able to co-participate in the treatment
  • Participants on psychotropic medication must have been on a stable dose for the last 3 months prior to baseline assessment

Exclusion Criteria:

  • Diagnosed autism spectrum disorder or Attention-deficit/hyperactivity disorder (ADHD), or principal primary disorder other than GAD, Separation anxiety, Specific phobia
  • Acute/severe psychiatric problems such as suicidal risk or severe depression
  • Ongoing psychological treatment for anxiety disorders
  • Ongoing child custody dispute or abuse in the family

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional
Behavioral: Internet-delivered Cognitive Behavior Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Clinical Global Impressions - severity (CGI-S)
Time Frame: baseline, post-treatment (12 weeks), follow-up (3 months)
Change in CGI-s from baseline to post-treatment and follow-up
baseline, post-treatment (12 weeks), follow-up (3 months)

Secondary Outcome Measures

Outcome Measure
Time Frame
Children´s Global Assessment Scale (CGAS
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Spence Child Anxiety Scale C/P (SCAS-C/P)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Penn State Worry Questionnaire (PSWQ)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Separation Anxiety Index (SAI)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Fear Survey Schedule for Children - Revised (FSSC-R)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Child Sheehan Disability Scale (CSDS)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Child Depression Inventory (CDI)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Hospital Anxiety Depression Scale (HAD)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)
Client Satisfaction Scale (CSS)
Time Frame: post-treatment (12 weeks)
post-treatment (12 weeks)
Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P)
Time Frame: Baseline, post-treatment (12 weeks), follow-up (3 months)
Baseline, post-treatment (12 weeks), follow-up (3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

September 27, 2014

First Submitted That Met QC Criteria

December 2, 2014

First Posted (Estimate)

December 3, 2014

Study Record Updates

Last Update Posted (Estimate)

January 20, 2016

Last Update Submitted That Met QC Criteria

January 18, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2014/1225-31/4

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Anxiety Disorder

Clinical Trials on Internet-delivered Cognitive Behavior Therapy

3
Subscribe